Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome

Mary Anne Berg, Jaime Guevara-Aguirre, Arlan L. Rosenbloom, Ronald (Ron) Rosenfeld, Uta Francke

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Laron syndrome is an autosomal recessive condition characterized by resistance to growth hormone. We sought to determine the molecular basis of this condition in an Ecuadorean population with a high incidence of affected individuals. Growth hormone receptor gene sequences from an obligate heterozygote were amplified by the polymerase chain reaction and screened for mutations using denaturing gradient gel electrophoresis. Only exon 6 revealed homo- and heteroduplexes on denaturing gradient gels. Sequencing revealed a substitution of guanine for adenine in the third position of codon 180 that did not change the amino acid encoded. Sequencing of the exon 6-exon 7 splice junction from RNA-polymerase chain reaction amplified cellular RNA of an affected individual revealed that the substitution activates a 5′ splice site 24 nucleotides upstream from the normal exon 6-intron 6 boundary. Splicing in two probands' lymphoblasts occurred virtually exclusively at the abnormal 5' splice site created by the codon 180 substitution. Exon 6 sequences from 38 patients and 47 relatives were amplified and analyzed by sequencing or dot-blot hybridization with allele-specific oligonucleotides. The substitution was detected in 74 of 76 Laron syndrome patients' GH-receptor alleles. All 26 parents and 12 of 21 unaffected siblings were heterozygous for this mutation. It was absent in 61 unrelated unaffected control individuals. We conclude that the codon 180 nucleotide substitution probably causes Laron syndrome as translation of the observed, abnormally spliced growth hormone receptor transcript would lead to the synthesis of a receptor protein with an 8 amino acid deletion from the extracellular domain.

Original languageEnglish (US)
Pages (from-to)24-34
Number of pages11
JournalHuman Mutation
Volume1
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Laron Syndrome
Somatotropin Receptors
Exons
Mutation
Codon
RNA Splice Sites
Genes
Nucleotides
Alleles
Amino Acids
Polymerase Chain Reaction
Denaturing Gradient Gel Electrophoresis
Guanine
Adenine
DNA-Directed RNA Polymerases
Heterozygote
Oligonucleotides
Introns
Growth Hormone
Siblings

Keywords

  • Growth hormone receptor
  • Laron dwarfism
  • Mutation
  • RNA splicing

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Berg, M. A., Guevara-Aguirre, J., Rosenbloom, A. L., Rosenfeld, R. R., & Francke, U. (1992). Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome. Human Mutation, 1(1), 24-34.

Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome. / Berg, Mary Anne; Guevara-Aguirre, Jaime; Rosenbloom, Arlan L.; Rosenfeld, Ronald (Ron); Francke, Uta.

In: Human Mutation, Vol. 1, No. 1, 1992, p. 24-34.

Research output: Contribution to journalArticle

Berg, MA, Guevara-Aguirre, J, Rosenbloom, AL, Rosenfeld, RR & Francke, U 1992, 'Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome', Human Mutation, vol. 1, no. 1, pp. 24-34.
Berg MA, Guevara-Aguirre J, Rosenbloom AL, Rosenfeld RR, Francke U. Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome. Human Mutation. 1992;1(1):24-34.
Berg, Mary Anne ; Guevara-Aguirre, Jaime ; Rosenbloom, Arlan L. ; Rosenfeld, Ronald (Ron) ; Francke, Uta. / Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome. In: Human Mutation. 1992 ; Vol. 1, No. 1. pp. 24-34.
@article{20f2915db7c94425a3e7abbe98aa33ae,
title = "Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome",
abstract = "Laron syndrome is an autosomal recessive condition characterized by resistance to growth hormone. We sought to determine the molecular basis of this condition in an Ecuadorean population with a high incidence of affected individuals. Growth hormone receptor gene sequences from an obligate heterozygote were amplified by the polymerase chain reaction and screened for mutations using denaturing gradient gel electrophoresis. Only exon 6 revealed homo- and heteroduplexes on denaturing gradient gels. Sequencing revealed a substitution of guanine for adenine in the third position of codon 180 that did not change the amino acid encoded. Sequencing of the exon 6-exon 7 splice junction from RNA-polymerase chain reaction amplified cellular RNA of an affected individual revealed that the substitution activates a 5′ splice site 24 nucleotides upstream from the normal exon 6-intron 6 boundary. Splicing in two probands' lymphoblasts occurred virtually exclusively at the abnormal 5' splice site created by the codon 180 substitution. Exon 6 sequences from 38 patients and 47 relatives were amplified and analyzed by sequencing or dot-blot hybridization with allele-specific oligonucleotides. The substitution was detected in 74 of 76 Laron syndrome patients' GH-receptor alleles. All 26 parents and 12 of 21 unaffected siblings were heterozygous for this mutation. It was absent in 61 unrelated unaffected control individuals. We conclude that the codon 180 nucleotide substitution probably causes Laron syndrome as translation of the observed, abnormally spliced growth hormone receptor transcript would lead to the synthesis of a receptor protein with an 8 amino acid deletion from the extracellular domain.",
keywords = "Growth hormone receptor, Laron dwarfism, Mutation, RNA splicing",
author = "Berg, {Mary Anne} and Jaime Guevara-Aguirre and Rosenbloom, {Arlan L.} and Rosenfeld, {Ronald (Ron)} and Uta Francke",
year = "1992",
language = "English (US)",
volume = "1",
pages = "24--34",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Mutation creating a new splice site in the growth hormone receptor genes of 37 ecuadorean patients with laron syndrome

AU - Berg, Mary Anne

AU - Guevara-Aguirre, Jaime

AU - Rosenbloom, Arlan L.

AU - Rosenfeld, Ronald (Ron)

AU - Francke, Uta

PY - 1992

Y1 - 1992

N2 - Laron syndrome is an autosomal recessive condition characterized by resistance to growth hormone. We sought to determine the molecular basis of this condition in an Ecuadorean population with a high incidence of affected individuals. Growth hormone receptor gene sequences from an obligate heterozygote were amplified by the polymerase chain reaction and screened for mutations using denaturing gradient gel electrophoresis. Only exon 6 revealed homo- and heteroduplexes on denaturing gradient gels. Sequencing revealed a substitution of guanine for adenine in the third position of codon 180 that did not change the amino acid encoded. Sequencing of the exon 6-exon 7 splice junction from RNA-polymerase chain reaction amplified cellular RNA of an affected individual revealed that the substitution activates a 5′ splice site 24 nucleotides upstream from the normal exon 6-intron 6 boundary. Splicing in two probands' lymphoblasts occurred virtually exclusively at the abnormal 5' splice site created by the codon 180 substitution. Exon 6 sequences from 38 patients and 47 relatives were amplified and analyzed by sequencing or dot-blot hybridization with allele-specific oligonucleotides. The substitution was detected in 74 of 76 Laron syndrome patients' GH-receptor alleles. All 26 parents and 12 of 21 unaffected siblings were heterozygous for this mutation. It was absent in 61 unrelated unaffected control individuals. We conclude that the codon 180 nucleotide substitution probably causes Laron syndrome as translation of the observed, abnormally spliced growth hormone receptor transcript would lead to the synthesis of a receptor protein with an 8 amino acid deletion from the extracellular domain.

AB - Laron syndrome is an autosomal recessive condition characterized by resistance to growth hormone. We sought to determine the molecular basis of this condition in an Ecuadorean population with a high incidence of affected individuals. Growth hormone receptor gene sequences from an obligate heterozygote were amplified by the polymerase chain reaction and screened for mutations using denaturing gradient gel electrophoresis. Only exon 6 revealed homo- and heteroduplexes on denaturing gradient gels. Sequencing revealed a substitution of guanine for adenine in the third position of codon 180 that did not change the amino acid encoded. Sequencing of the exon 6-exon 7 splice junction from RNA-polymerase chain reaction amplified cellular RNA of an affected individual revealed that the substitution activates a 5′ splice site 24 nucleotides upstream from the normal exon 6-intron 6 boundary. Splicing in two probands' lymphoblasts occurred virtually exclusively at the abnormal 5' splice site created by the codon 180 substitution. Exon 6 sequences from 38 patients and 47 relatives were amplified and analyzed by sequencing or dot-blot hybridization with allele-specific oligonucleotides. The substitution was detected in 74 of 76 Laron syndrome patients' GH-receptor alleles. All 26 parents and 12 of 21 unaffected siblings were heterozygous for this mutation. It was absent in 61 unrelated unaffected control individuals. We conclude that the codon 180 nucleotide substitution probably causes Laron syndrome as translation of the observed, abnormally spliced growth hormone receptor transcript would lead to the synthesis of a receptor protein with an 8 amino acid deletion from the extracellular domain.

KW - Growth hormone receptor

KW - Laron dwarfism

KW - Mutation

KW - RNA splicing

UR - http://www.scopus.com/inward/record.url?scp=0027024834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027024834&partnerID=8YFLogxK

M3 - Article

C2 - 1284474

AN - SCOPUS:0027024834

VL - 1

SP - 24

EP - 34

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 1

ER -